JAMA Network Open
EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 6, 2019
Media advisory: The full study and commentary are linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2019.14729?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110619
About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Wednesday and Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.
What The Study Did: This randomized clinical trial compared mailed at-home HPV self-sampling test kits with the usual care reminders patients receive about in-clinic screening for increasing the detection and treatment of cervical precancers and screening.
Authors: Rachel L. Winer, Ph.D., of the University of Washington in Seattle, is the corresponding author.
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.